Sumitomo Mitsui DS Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.39M Sell
15,999
-51
-0.3% -$10K 0.02% 438
2026
Q1
$3.15M Sell
16,050
-59
-0.4% -$11.5K 0.03% 425
2025
Q4
$2.8M Buy
16,109
+2,918
+22% +$531K 0.02% 441
2025
Q3
$2.51M Sell
13,191
-39
-0.3% -$6.92K 0.02% 457
2025
Q2
$2.38M Buy
13,230
+300
+2% +$52.1K 0.02% 455
2025
Q1
$2.19M Buy
12,930
+354
+3% +$58.2K 0.02% 465
2024
Q4
$1.9M Buy
12,576
+237
+2% +$36.9K 0.02% 502
2024
Q3
$1.92M Buy
12,339
+289
+2% +$43.2K 0.02% 490
2024
Q2
$1.65M Buy
12,050
+197
+2% +$27K 0.02% 490
2024
Q1
$1.58M Buy
11,853
+2,110
+22% +$274K 0.02% 502
2023
Q4
$1.34M Buy
9,743
+36
+0.4% +$4.73K 0.02% 544
2023
Q3
$1.18M Buy
9,707
+108
+1% +$14.4K 0.02% 519
2023
Q2
$1.35M Buy
9,599
+2
+0% +$276 0.02% 489
2023
Q1
$1.36M Buy
9,597
+149
+2% +$21.3K 0.02% 471
2022
Q4
$1.48M Buy
9,448
+831
+10% +$119K 0.03% 428
2022
Q3
$1.06M Buy
8,617
+154
+2% +$20.3K 0.02% 483
2022
Q2
$1.13M Buy
8,463
+470
+6% +$64K 0.03% 456
2022
Q1
$1.09M Sell
7,993
-49
-0.6% -$6.83K 0.02% 496
2021
Q4
$1.39M Sell
8,042
-32
-0.4% -$4.87K 0.03% 448
2021
Q3
$1.17M Sell
8,074
-162
-2% -$23.7K 0.03% 461
2021
Q2
$1.09M Sell
8,236
-26
-0.3% -$3.4K 0.03% 491
2021
Q1
$1.06M Buy
8,262
+36
+0.4% +$4.44K 0.03% 471
2020
Q4
$980K Sell
8,226
-536
-6% -$65.3K 0.03% 456
2020
Q3
$1M Buy
8,762
+28
+0.3% +$3.31K 0.03% 408
2020
Q2
$995K Buy
8,734
+687
+9% +$72.9K 0.03% 394
2020
Q1
$646K Sell
8,047
-198
-2% -$20.5K 0.03% 443
2019
Q4
$880K Hold
8,245
0.03% 451
2019
Q3
$882K Buy
8,245
+904
+12% +$92.8K 0.03% 425
2019
Q2
$747K Sell
7,341
-2,180
-23% -$209K 0.03% 442
2019
Q1
$856K Hold
9,521
0.01% 557
2018
Q4
$792K Hold
9,521
0.01% 524
2018
Q3
$1.03M Buy
9,521
+94
+1% +$10.3K 0.02% 503
2018
Q2
$1.04M Sell
9,427
-37,674
-80% -$3.92M 0.02% 498
2018
Q1
$4.72M Buy
47,101
+1,886
+4% +$193K 0.07% 212
2017
Q4
$4.45M Buy
45,215
+34,227
+311% +$3.24M 0.07% 230
2017
Q3
$1.03M Buy
10,988
+39
+0.4% +$4.14K 0.02% 480
2017
Q2
$1.22M Sell
10,949
-884
-7% -$93.5K 0.02% 432
2017
Q1
$1.16M Buy
11,833
+1,458
+14% +$139K 0.02% 440
2016
Q4
$953K Sell
10,375
-252
-2% -$21.7K 0.02% 455
2016
Q3
$899K Sell
10,627
-30
-0.3% -$2.52K 0.02% 467
2016
Q2
$867K Buy
10,657
+142
+1% +$10.8K 0.03% 438
2016
Q1
$751K Buy
10,515
+181
+2% +$12.1K 0.02% 496
2015
Q4
$735K Sell
10,334
-900
-8% -$60.5K 0.02% 485
2015
Q3
$690K Buy
11,234
+64
+0.6% +$4.47K 0.02% 513
2015
Q2
$810K Sell
11,170
-517
-4% -$38.2K 0.03% 499
2015
Q1
$898K Sell
11,687
-847
-7% -$60.7K 0.03% 489
2014
Q4
$840K Sell
12,534
-231
-2% -$14.6K 0.03% 516
2014
Q3
$774K Sell
12,765
-1,216
-9% -$74.9K 0.02% 549
2014
Q2
$820K Sell
13,981
-3,071
-18% -$180K 0.02% 557
2014
Q1
$987K Sell
17,052
-143
-0.8% -$7.66K 0.03% 507
2013
Q4
$920K Sell
17,195
-2,183
-11% -$129K 0.03% 534
2013
Q3
$1.2M Sell
19,378
-137
-0.7% -$8.2K 0.03% 437
2013
Q2
$1.18M Buy
+19,515
New +$1.16M 0.03% 430

Other funds holding DGX

Sumitomo Mitsui DS Asset Management's DGX Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management reduced its Quest Diagnostics (DGX) stake by 0.32% in Q2 2026, selling an estimated $10K and leaving 15,999 shares worth $3.39M. The position accounts for 0.02% of the portfolio, ranked #438.

Sumitomo Mitsui DS Asset Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.72M in Q1 2018. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 15,999 shares of Quest Diagnostics worth $3.39M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management sold 51 Quest Diagnostics shares in Q2 2026, an estimated $10K.
  • Quest Diagnostics made up 0.02% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #438 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Sumitomo Mitsui DS Asset Management's Quest Diagnostics position peaked at $4.72M in Q1 2018.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.